Published in Arch Intern Med on March 09, 1998
Peripheral Venous Catheter Related Blood Stream Infections | NCT05139628
Guidelines for the prevention of intravascular catheter-related infections. Clin Infect Dis (2011) 4.09
Summary of recommendations: Guidelines for the Prevention of Intravascular Catheter-related Infections. Clin Infect Dis (2011) 2.49
Improving the safety of peripheral intravenous catheters. BMJ (2008) 1.51
Catheter-associated infections: pathogenesis affects prevention. Arch Intern Med (2004) 1.48
Prevention of central venous catheter-related infection in the intensive care unit. Crit Care (2010) 1.19
Incidence and clinical implication of nosocomial infections associated with implantable biomaterials - catheters, ventilator-associated pneumonia, urinary tract infections. GMS Krankenhhyg Interdiszip (2011) 1.06
Nosocomial Infections in the Intensive Care Unit Associated with Invasive Medical Devices. Curr Infect Dis Rep (2001) 0.87
Pharmacokinetics and safety study of posaconazole intravenous solution administered peripherally to healthy subjects. Antimicrob Agents Chemother (2014) 0.83
New technologies to prevent intravascular catheter-related bloodstream infections. Emerg Infect Dis (2001) 0.83
Effectiveness of a Drill-assisted Intraosseous Catheter versus Manual Intraosseous Catheter by Resident Physicians in a Swine Model. West J Emerg Med (2013) 0.82
The value of procalcitonin and the SAPS II and APACHE III scores in the differentiation of infectious and non-infectious fever in the ICU: a prospective, cohort study. J Korean Med Sci (2010) 0.81
Mastery learning improves students skills in inserting intravenous access: a pre-post-study. GMS J Med Educ (2016) 0.79
Peripheral Venous Catheter-Related Adverse Events: Evaluation from a Multicentre Epidemiological Study in France (the CATHEVAL Project). PLoS One (2017) 0.75
Access technique and its problems in parenteral nutrition - Guidelines on Parenteral Nutrition, Chapter 9. Ger Med Sci (2009) 0.75
Central Venous Line Placement prior to Gastric Bypass Improves Operating Room Efficiency. ISRN Surg (2012) 0.75
Infection risks associated with peripheral vascular catheters. J Infect Prev (2016) 0.75
Peripheral venous catheter-related bloodstream infection is associated with severe complications and potential death: a retrospective observational study. BMC Infect Dis (2017) 0.75
Sexual transmission of HIV-1 among injection drug users in San Francisco, USA: risk-factor analysis. Lancet (2001) 5.28
Multiple antibiotic-resistant Klebsiella and Escherichia coli in nursing homes. JAMA (1999) 5.26
Transmission from one child to another of human immunodeficiency virus type 1 with a zidovudine-resistance mutation. N Engl J Med (1993) 5.00
Strategies to Prevent and Control the Emergence and Spread of Antimicrobial-Resistant Microorganisms in Hospitals. A challenge to hospital leadership. JAMA (1996) 4.80
Predictors and prevention of nonfatal overdose among street-recruited injection heroin users in the San Francisco Bay Area, 1998-1999. Am J Public Health (2001) 3.43
Colonization of skilled-care facility residents with antimicrobial-resistant pathogens. J Am Geriatr Soc (2001) 3.06
The role of "colonization pressure" in the spread of vancomycin-resistant enterococci: an important infection control variable. Arch Intern Med (1998) 2.94
Vancomycin-resistant enterococci in intensive-care hospital settings: transmission dynamics, persistence, and the impact of infection control programs. Proc Natl Acad Sci U S A (1999) 2.75
High prevalence of abscesses and cellulitis among community-recruited injection drug users in San Francisco. Clin Infect Dis (2000) 2.71
Transfusion-associated acquired immunodeficiency syndrome. Evidence for persistent infection in blood donors. N Engl J Med (1985) 2.62
Development of Daptomycin resistance in vivo in methicillin-resistant Staphylococcus aureus. J Clin Microbiol (2005) 2.53
Ceftazidime-resistant Klebsiella pneumoniae and Escherichia coli bloodstream infection: a case-control and molecular epidemiologic investigation. J Infect Dis (1996) 2.49
Identity and interspecific transfer of gentamicin-resistance plasmids in Staphylococcus aureus and Staphylococcus epidermidis. J Infect Dis (1980) 2.48
Are active microbiological surveillance and subsequent isolation needed to prevent the spread of methicillin-resistant Staphylococcus aureus? Clin Infect Dis (2005) 2.47
Vancomycin-resistant enterococci: why are they here, and where do they come from? Lancet Infect Dis (2001) 2.46
Epidemiology of colonisation of patients and environment with vancomycin-resistant enterococci. Lancet (1996) 2.44
A comparison of the effect of universal use of gloves and gowns with that of glove use alone on acquisition of vancomycin-resistant enterococci in a medical intensive care unit. Ann Intern Med (1996) 2.38
Medical and surgical treatment of parapneumonic effusions : an evidence-based guideline. Chest (2000) 2.36
Ninety-minute exclusion of acute myocardial infarction by use of quantitative point-of-care testing of myoglobin and troponin I. Circulation (2001) 2.22
The effect of syringe exchange use on high-risk injection drug users: a cohort study. AIDS (2000) 2.20
Genetically diverse ceftazidime-resistant isolates from a single center: biochemical and genetic characterization of TEM-10 beta-lactamases encoded by different nucleotide sequences. Antimicrob Agents Chemother (1993) 2.03
Antimicrobial resistance rates among aerobic gram-negative bacilli recovered from patients in intensive care units: evaluation of a national postmarketing surveillance program. Clin Infect Dis (1996) 2.03
Prevalence and duration of hepatitis C among injection drug users in San Francisco, Calif. Am J Public Health (2001) 2.02
Risk factors among IDUs who give injections to or receive injections from other drug users. Addiction (1999) 1.94
Epidemics of nosocomial urinary tract infection caused by multiply resistant gram-negative bacilli: epidemiology and control. J Infect Dis (1976) 1.92
Structural and phenotypic varieties of gentamicin resistance plasmids in hospital strains of Staphylococcus aureus and coagulase-negative staphylococci. Antimicrob Agents Chemother (1982) 1.89
Pseudoepidemics in hospital. Lancet (1977) 1.89
Risk factors for skin and soft-tissue abscesses among injection drug users: a case-control study. Clin Infect Dis (2001) 1.88
Sex- and drug-related risk among populations of younger and older injection drug users in adjacent neighborhoods in San Francisco. J Acquir Immune Defic Syndr (2000) 1.87
Sex trading and psychological distress among women recruited from the streets of Harlem. Am J Public Health (1997) 1.81
Breast abscess: coagulase-negative staphylococcus as a sole pathogen. Clin Infect Dis (1993) 1.72
Crack cocaine smoking and oral sores in three inner-city neighborhoods. J Acquir Immune Defic Syndr Hum Retrovirol (1996) 1.65
"Inadvertent" thrombolytic administration in patients without myocardial infarction: clinical features and outcome. Ann Emerg Med (1996) 1.61
External sources of vancomycin-resistant enterococci for intensive care units. Crit Care Med (1998) 1.59
Hospital outbreaks caused by Pseudomonas aeruginosa: importance of serogroup O11. J Clin Microbiol (1982) 1.58
Tuberculosis in patients infected with human immunodeficiency virus: perspective on the past decade. Clin Infect Dis (1996) 1.56
Gentamicin-resistant staphylococci as hospital flora: epidemiology and resistance plasmids. J Infect Dis (1982) 1.54
Association of infection caused by Pseudomonas aeruginosa serotype O11 with intravenous abuse of pentazocine mixed with tripelennamine. J Clin Microbiol (1984) 1.54
AIDS-related Pneumocystis carinii pneumonia in older patients. J Gen Intern Med (1996) 1.54
Stability of vancomycin-resistant enterococcal genotypes isolated from long-term-colonized patients. J Infect Dis (1998) 1.53
Variations in intensive care unit utilization for patients with human immunodeficiency virus-related Pneumocystis carinii pneumonia: importance of hospital characteristics and geographic location. Crit Care Med (1998) 1.52
Quality of history taking in patients with aortic dissection. Chest (1998) 1.51
Insemination of HIV-negative women with processed semen of HIV-positive partners. Lancet (1993) 1.50
Patients' endogenous flora as the source of "nosocomial" Enterobacter in cardiac surgery. J Infect Dis (1987) 1.49
Relationship between procedures and health insurance for critically ill patients with Pneumocystis carinii pneumonia. Am J Respir Crit Care Med (1995) 1.48
Randomized trial of an oral platelet glycoprotein IIb/IIIa antagonist, sibrafiban, in patients after an acute coronary syndrome: results of the TIMI 12 trial. Thrombolysis in Myocardial Infarction. Circulation (1998) 1.47
Epidemiology of endemic Pseudomonas aeruginosa: why infection control efforts have failed. J Infect Dis (1984) 1.46
Diphtheria in the United States, 1971-81. Am J Public Health (1985) 1.44
Determinants of mortality after myocardial infarction in patients with advanced renal dysfunction. Am J Kidney Dis (2001) 1.42
The high-risk sexual practices of crack-smoking sex workers recruited from the streets of three American cities. The Multicenter Crack Cocaine and HIV Infection Study Team. Sex Transm Dis (1998) 1.42
Short-term hemodynamic effects of endothelin receptor blockade in dogs with chronic heart failure. Circulation (1996) 1.41
Early detection of false-positive acid-fast smears. An epidemiological approach. Lancet (1975) 1.39
Magnitude and prevention of nosocomial infections in the intensive care unit. Infect Dis Clin North Am (1997) 1.37
Effectiveness of gloves in the prevention of hand carriage of vancomycin-resistant enterococcus species by health care workers after patient care. Clin Infect Dis (2001) 1.36
Variations in institutional review board decisions for HIV quality of care studies: a potential source of study bias. J Acquir Immune Defic Syndr (2001) 1.36
Individuals from North America, Australasia, and Africa are infected with four different genotypes of human herpesvirus 8. Virology (1999) 1.32
Pressure monitoring devices. Overlooked source of nosocomial infection. JAMA (1976) 1.31
Comparison of endemic and epidemic nosocomial infections. Am J Med (1981) 1.31
Crack cocaine smokers who turn to drug injection: characteristics, factors associated with injection, and implications for HIV transmission. The Multicenter Crack Cocaine and HIV Infection Study Team. Drug Alcohol Depend (1996) 1.31
Improvements in outcomes of acute respiratory failure for patients with human immunodeficiency virus-related Pneumocystis carinii pneumonia. Am J Respir Crit Care Med (2000) 1.30
Multiresistant bacteria as a hospital epidemic problem. Ann Med (1998) 1.27
How safely and for how long can warfarin therapy be withheld in prosthetic heart valve patients hospitalized with a major hemorrhage? Chest (2001) 1.27
Endemic emergence of cephalosporin-resistant Enterobacter: relation to prior therapy. Infect Control (1986) 1.26
Myocarditis and pericarditis with tamponade associated with disseminated tuberculosis. Can J Cardiol (2000) 1.25
Broad-spectrum beta-lactam resistance in Enterobacter: emergence during treatment and mechanisms of resistance. J Antimicrob Chemother (1983) 1.24
Trends in HIV seroprevalence and risk among gay and bisexual men who inject drugs in San Francisco, 1988 to 2000. J Acquir Immune Defic Syndr (2001) 1.22
An outbreak of pneumocystis pneumonia in children with acute lymphocytic leukemia. Am J Dis Child (1978) 1.22
The inverse relationship between chronic HBV and HCV infections among injection drug users is associated with decades of age and drug use. J Viral Hepat (2008) 1.22
Risk of hepatitis B infection among young injection drug users in San Francisco: opportunities for intervention. West J Med (2000) 1.21
Use of an illegal syringe exchange and injection-related risk behaviors among street-recruited injection drug users in Oakland, California, 1992 to 1995. J Acquir Immune Defic Syndr Hum Retrovirol (1998) 1.21
Hepatitis C virus-specific T-cell immune responses in seronegative injection drug users. J Viral Hepat (2008) 1.21
Endemic aminoglycoside resistance in gram-negative bacilli: epidemiology and mechanisms. J Infect Dis (1980) 1.20
Occult aminoglycoside resistance in Pseudomonas aeruginosa: epidemiology and implications for therapy and control. J Infect Dis (1985) 1.19
Incentives and accessibility: a pilot study to promote adherence to TB prophylaxis in a high-risk community. J Urban Health (1999) 1.19
The epidemiology of Pseudomonas aeruginosa in oncology patients in a general hospital. J Infect Dis (1989) 1.17
Crack cocaine use and sexual activity in Miami, Florida. J Psychoactive Drugs (1993) 1.12
Skin colonization with vancomycin-resistant enterococci among hospitalized patients with bacteremia. Clin Infect Dis (1997) 1.11
Antibiotic-resistant flora in nursing home patients admitted to the hospital. Arch Intern Med (1985) 1.10
The changing molecular epidemiology and establishment of endemicity of vancomycin resistance in enterococci at one hospital over a 6-year period. J Infect Dis (1999) 1.10
Bowel colonization with resistant gram-negative bacilli after antimicrobial therapy of intra-abdominal infections: observations from two randomized comparative clinical trials of ertapenem therapy. Eur J Clin Microbiol Infect Dis (2005) 1.09
Racial differences in care among hospitalized patients with Pneumocystis carinii pneumonia in Chicago, New York, Los Angeles, Miami, and Raleigh-Durham. Arch Intern Med (1995) 1.09
Lessons from an epidemic, again. N Engl J Med (2001) 1.07
Risk factors for antibiotic-resistant infection and treatment outcomes among hospitalized patients transferred from long-term care facilities: does antimicrobial choice make a difference? Clin Infect Dis (2003) 1.06
Reactive hemophagocytic syndrome: a new presentation of disseminated histoplasmosis in patients with AIDS. Clin Infect Dis (1995) 1.06
Strategies for prevention and control of multiple drug-resistant nosocomial infection. Am J Med (1981) 1.04
Pressure transducers as a source of bacteremia after open heart surgery. Report of an outbreak and guidelines for prevention. Chest (1976) 1.03
Sex trading and psychological distress in a street-based sample of low-income urban men. J Psychoactive Drugs (2001) 1.03
Hepatitis C patients' self-reported adherence to treatment with pegylated interferon and ribavirin. Aliment Pharmacol Ther (2008) 1.02
Control of aminoglycoside resistance by barrier precautions. Infect Control (1983) 1.01
The role of colonization in the pathogenesis of nosocomial infections. Infect Control Hosp Epidemiol (1996) 1.01
Caribbean sponge-related Pseudomonas folliculitis. JAMA (1987) 1.01
Hairy cell leukemia: association with disseminated atypical mycobacterial infection. Cancer (1981) 1.00
The case for face masks-zorro or zero? Clin Infect Dis (2000) 1.00
A new preadmission staging system for predicting inpatient mortality from HIV-associated Pneumocystis carinii pneumonia in the early highly active antiretroviral therapy (HAART) era. Am J Respir Crit Care Med (2000) 0.99
Risks associated with renal dysfunction in patients in the coronary care unit. J Am Coll Cardiol (2000) 0.99
Pilot trial of selective decontamination for prevention of bacterial infection in an intensive care unit. J Infect Dis (1990) 0.98
The effect of renal dysfunction on antimicrobial use measurements. Clin Infect Dis (2002) 0.98
Factitious meningitis. Diagnostic error due to nonviable bacteria in commercial lumbar puncture trays. JAMA (1975) 0.96